Ammonium lactate - Bristol-Myers Squibb

Drug Profile

Ammonium lactate - Bristol-Myers Squibb

Alternative Names: BMS-186091; Lac-Hydrin

Latest Information Update: 16 Jan 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Bristol-Myers Squibb
  • Class Lactates; Sulfhydryl compounds
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Marketed Dry skin; Ichthyosis
  • Discontinued Photodamage

Most Recent Events

  • 16 Oct 2000 Launched for Ichthyosis in USA (Topical)
  • 16 Oct 2000 Launched for Xerosis cutis in USA (Topical)
  • 28 Apr 1998 Phase-III clinical trials for Photodamage in USA (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top